(Q32078743)

6 July 2017

title

Intravenous clomipramine decreases excitability of human motor cortex. A study with paired magnetic stimulation (English)

1 reference

6 July 2017

1 reference

Manganotti P

1

1 reference

6 July 2017

Bortolomasi M

2

1 reference

6 July 2017

Zanette G

3

1 reference

6 July 2017

Pawelzik T

4

1 reference

6 July 2017

Giacopuzzi M

5

1 reference

6 July 2017

Fiaschi A

6

1 reference

6 July 2017

language of work or name

1 reference

1 February 2001

1 reference

Journal of the Neurological Sciences

6 July 2017

published in

1 reference

6 July 2017

volume

184

1 reference

6 July 2017

issue

1

1 reference

6 July 2017

page(s)

27-32

1 reference

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Intravenous clomipramine for obsessive-compulsive disorder refractory to oral clomipramine: a placebo-controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

EEG activation after intravenous amitriptyline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Antidepressants and convulsive seizures: clinical, electroencephalographic, and pharmacological aspects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Incidence of seizures with tricyclic and tetracyclic antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Magnetic motor-evoked potentials in epilepsy: effects of the disease and of anticonvulsant medication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

'Excitability changes of muscular responses to magnetic brain stimulation in patients with central motor disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Transcranial magnetic stimulation in epileptic patients: usefulness and safety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Effects of diazepam, baclofen and thiopental on the silent period evoked by transcranial magnetic stimulation in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Effects of diphenylhydantoin on motor potentials evoked with magnetic stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Cortical excitability in patients after loading doses of lamotrigine: a study with magnetic brain stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

GABA as an inhibitory neurotransmitter in human cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Spinal motor neuron excitability during the silent period after cortical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Magnetic brain stimulation: the silent period after the motor evoked potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Motor inhibition and excitation are independent effects of magnetic cortical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

The muscle silent period following transcranial magnetic cortical stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Corticocortical inhibition in human motor cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

The effect of lorazepam on the motor cortical excitability in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Inhibition of human motor cortex by ethanol. A transcranial magnetic stimulation study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

The glutamate antagonist riluzole suppresses intracortical facilitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Optimal focal transcranial magnetic activation of the human motor cortex: effects of coil orientation, shape of the induced current pulse, and stimulus intensity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Crossed and direct effects of digital nerves stimulation on motor evoked potential: a study with magnetic brain stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Sleep and treatment prediction in endogenous depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

Effects of antipsychotic medication on electromyographic responses to transcranial magnetic stimulation of the motor cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2800%2900495-0

10.1016/S0022-510X(00)00495-0

7 January 2021

Identifiers

DOI

1 reference

6 July 2017

1 reference